Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Infinity Pharmaceuticals
(NQ:
INFI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Infinity Pharmaceuticals
< Previous
1
2
3
4
Next >
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
August 17, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Via
Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
August 11, 2022
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 10, 2022
Via
Benzinga
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 10, 2022
Gainers
Via
Benzinga
Infinity Pharmaceuticals: Q2 Earnings Insights
August 09, 2022
Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 09, 2022
Via
Benzinga
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
August 10, 2022
Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.
Via
Benzinga
Infinity Pharmaceuticals's Return On Capital Employed Insights
May 13, 2022
Benzinga Pro data, Infinity Pharmaceuticals (NASDAQ:INFI) reported Q1 sales of $652.00 thousand. Earnings fell to a loss of $12.44 million, resulting in a 6.74% decrease from last quarter.
Via
Benzinga
70 Biggest Movers From Friday
May 31, 2022
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for...
Via
Benzinga
Infinity Pharmaceuticals: Q1 Earnings Insights
May 03, 2022
Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
81 Biggest Movers From Yesterday
May 18, 2022
Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
99 Biggest Movers From Yesterday
May 12, 2022
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
Via
Benzinga
Infinity Pharmaceuticals Earnings Preview
May 02, 2022
Infinity Pharmaceuticals (NASDAQ:INFI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
51 Biggest Movers From Yesterday
March 31, 2022
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 30, 2022
Gainers Adagio Therapeutics (NASDAQ:ADGI) shares rose 40.0% to $5.39 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 80.0...
Via
Benzinga
Infinity Pharmaceuticals Earnings Perspective: Return On Capital Employed
March 30, 2022
Infinity Pharmaceuticals (NASDAQ:INFI) brought in sales totaling $451.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.76%, resulting in a loss of $11.65...
Via
Benzinga
Earnings Scheduled For March 29, 2022
March 29, 2022
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
Via
Benzinga
Infinity Pharmaceuticals Earnings Preview
March 28, 2022
Infinity Pharmaceuticals (NASDAQ:INFI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
50 Biggest Movers From Yesterday
January 06, 2022
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 05, 2022
Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...
Via
Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
December 10, 2021
Infinity Pharmaceuticals Inc (NASDAQ: INFI) presented updated data from the ongoing MARIO-3 study during the 2021 San Antonio Breast Cancer Symposium (SABCS)....
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 10, 2021
Gainers Reshape Lifesciences (NASDAQ:RSLS...
Via
Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...
Via
Benzinga
Infinity Pharmaceuticals's Return On Capital Employed Insights
November 02, 2021
According to data from Benzinga Pro, during Q2, Infinity Pharmaceuticals's (NASDAQ:INFI) reported sales totaled $512.00 thousand. Despite a 2.86% increase in earnings, the company...
Via
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today
October 18, 2021
An analyst initiated coverage of the biotech stock with a unambiguous buy recommendation.
Via
The Motley Fool
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
August 09, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 03, 2021
Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.